Pierre Louis Léger

522 total citations
9 papers, 347 citations indexed

About

Pierre Louis Léger is a scholar working on Pulmonary and Respiratory Medicine, Emergency Medicine and Biomedical Engineering. According to data from OpenAlex, Pierre Louis Léger has authored 9 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 3 papers in Emergency Medicine and 3 papers in Biomedical Engineering. Recurrent topics in Pierre Louis Léger's work include Mechanical Circulatory Support Devices (3 papers), Cardiac Arrest and Resuscitation (3 papers) and Respiratory Support and Mechanisms (2 papers). Pierre Louis Léger is often cited by papers focused on Mechanical Circulatory Support Devices (3 papers), Cardiac Arrest and Resuscitation (3 papers) and Respiratory Support and Mechanisms (2 papers). Pierre Louis Léger collaborates with scholars based in France, United Kingdom and Luxembourg. Pierre Louis Léger's co-authors include Mehdi Oualha, Guillaume Geslain, Diala Khraiche, Sylvain Renolleau, Julie Starck, Marion Grimaud, Judith Chareyre, Géraldine Poncelet, Marianne Leruez‐Ville and Florence Moulin and has published in prestigious journals such as Brain, Anesthesia & Analgesia and Clinical Microbiology and Infection.

In The Last Decade

Pierre Louis Léger

9 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre Louis Léger France 5 177 131 73 61 53 9 347
Constance Beyler France 8 175 1.0× 59 0.5× 38 0.5× 139 2.3× 27 0.5× 17 396
Michael Eyre United Kingdom 7 97 0.5× 194 1.5× 22 0.3× 31 0.5× 26 0.5× 13 356
Alyaa Kotby Egypt 10 82 0.5× 81 0.6× 27 0.4× 38 0.6× 11 0.2× 25 341
Alan Staples Australia 9 74 0.4× 28 0.2× 25 0.3× 32 0.5× 34 0.6× 12 358
Amy Pan United States 9 75 0.4× 12 0.1× 43 0.6× 35 0.6× 26 0.5× 53 271
Jessica Taytard France 11 96 0.5× 46 0.4× 23 0.3× 229 3.8× 8 0.2× 36 480
Makiko Ohyama Japan 14 153 0.9× 24 0.2× 17 0.2× 196 3.2× 52 1.0× 31 544
A. Cordier France 9 100 0.6× 24 0.2× 29 0.4× 26 0.4× 33 0.6× 17 366
Alireza Mohebbi Iran 10 169 1.0× 92 0.7× 106 1.5× 37 0.6× 6 0.1× 40 532
M Med South Africa 8 77 0.4× 107 0.8× 6 0.1× 33 0.5× 19 0.4× 12 307

Countries citing papers authored by Pierre Louis Léger

Since Specialization
Citations

This map shows the geographic impact of Pierre Louis Léger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Louis Léger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Louis Léger more than expected).

Fields of papers citing papers by Pierre Louis Léger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Louis Léger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Louis Léger. The network helps show where Pierre Louis Léger may publish in the future.

Co-authorship network of co-authors of Pierre Louis Léger

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Louis Léger. A scholar is included among the top collaborators of Pierre Louis Léger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Louis Léger. Pierre Louis Léger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Hirt, Déborah, Yi Zheng, Emmanuelle Bille, et al.. (2022). Cefepime population pharmacokinetics and dosing regimen optimization in critically ill children with different renal function. Clinical Microbiology and Infection. 28(10). 1389.e1–1389.e7. 10 indexed citations
2.
Grimaud, Marion, Julie Starck, Michaël Levy, et al.. (2020). Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children. Annals of Intensive Care. 10(1). 69–69. 223 indexed citations
3.
Genuini, Mathieu, et al.. (2020). A twelve‐year neonatal and pediatric high‐frequency oscillatory ventilation transport experience. Pediatric Pulmonology. 56(5). 1230–1236. 4 indexed citations
4.
Guellec, Isabelle, Sandrine Jean, M. Demoulin, et al.. (2019). Nosocomial Infections in Neonates Supported by Extracorporeal Membrane Oxygenation: First French Retrospective Study. Indian Journal of Critical Care Medicine. 23(9). 392–395. 3 indexed citations
5.
Gaudard, Philippe, Bertrand Rozec, Philippe Mauriat, et al.. (2018). New Modalities for the Administration of Inhaled Nitric Oxide in Intensive Care Units After Cardiac Surgery or for Neonatal Indications: A Prospective Observational Study. Anesthesia & Analgesia. 126(4). 1234–1240. 3 indexed citations
6.
Guedj, Romain, Hélène Chappuy, Luigi Titomanlio, et al.. (2017). Do All Children Who Present With a Complex Febrile Seizure Need a Lumbar Puncture?. Annals of Emergency Medicine. 70(1). 52–62.e6. 22 indexed citations
7.
Rambaud, Jérôme, et al.. (2016). International aircraft ECMO transportation: first French pediatric experience. Perfusion. 32(3). 253–255. 7 indexed citations
8.
Bahi‐Buisson, Nadia, Isabelle Souville, Franck J. Fourniol, et al.. (2013). New insights into genotype–phenotype correlations for the doublecortin-related lissencephaly spectrum. Brain. 136(1). 223–244. 74 indexed citations
9.
Léger, Pierre Louis. (2002). [History and fading of bladder stones].. PubMed. 52(10). 1053–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026